Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who are willing to give written consent to participate.
- People who have been clinically diagnosed with a neuroendocrine tumor (a type of tumor that can affect hormone production) that is causing the body to produce too much insulin, leading to dangerously low blood sugar levels, confirmed through lab tests.
- People whose low blood sugar has not been adequately controlled despite standard treatments, as determined by the treating doctor.
- People who have been receiving glucose through a drip (IV) or through nutritional support delivered directly into the bloodstream for at least 7 days before starting the trial, to manage their low blood sugar.
- Eligibility for all participants must be reviewed and confirmed by a specialist medical team, including an oncologist (cancer specialist), led by the principal investigator.
Who may not be able to join:
- People who have an active infection, including HIV, hepatitis B, or hepatitis C (not related to vaccination history).
- People who have taken part in another clinical drug or device trial within the past 30 days, or within 5 half-lives of that investigational drug — whichever is the longer period (though exceptions may be considered by the medical team in certain circumstances; participation in registries or purely diagnostic studies is allowed).
- People whose blood test results at the screening stage (other than blood sugar levels) show values outside the normal range that the investigator considers clinically significant (some exceptions may be allowed if the abnormality is related to the tumor or its treatment and does not pose additional risk).
- People who are known to have an allergy or sensitivity to ersodetug (the study drug) or any of its ingredients.
- People who have another serious health condition — such as a significant psychiatric illness, severe alcohol or drug dependence, or serious heart, liver, or kidney disease — that the investigator or medical monitor believes would make participation unsafe.
- People whose underlying disease is estimated to give them a remaining life expectancy of less than 8 weeks.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 650-206-4507
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants with clinically meaningful reduction in IV glucose infusion rate from baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.